Literature DB >> 30626961

A father's fight to help his sons - and fix clinical trials.

David Adam.   

Abstract

Keywords:  Diseases; Genetics; Medical research; Therapeutics

Mesh:

Substances:

Year:  2019        PMID: 30626961     DOI: 10.1038/d41586-019-00035-x

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  The nature of the defect in tyrosine metabolism in alcaptonuria.

Authors:  B N LA DU; V G ZANNONI; L LASTER; J E SEEGMILLER
Journal:  J Biol Chem       Date:  1958-01       Impact factor: 5.157

2.  A 3-year randomized therapeutic trial of nitisinone in alkaptonuria.

Authors:  Wendy J Introne; Monique B Perry; James Troendle; Ekaterini Tsilou; Michael A Kayser; Pim Suwannarat; Kevin E O'Brien; Joy Bryant; Vandana Sachdev; James C Reynolds; Elizabeth Moylan; Isa Bernardini; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-05-06       Impact factor: 4.797

3.  Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.

Authors:  L R Ranganath; M Khedr; A M Milan; A S Davison; A T Hughes; J L Usher; S Taylor; N Loftus; A Daroszewska; E West; A Jones; M Briggs; M Fisher; M McCormick; S Judd; S Vinjamuri; R Griffin; E E Psarelli; T F Cox; N Sireau; J P Dillon; J M Devine; G Hughes; J Harrold; G J Barton; J C Jarvis; J A Gallagher
Journal:  Mol Genet Metab       Date:  2018-07-24       Impact factor: 4.797

4.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Authors:  S Lindstedt; E Holme; E A Lock; O Hjalmarson; B Strandvik
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

5.  Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.

Authors:  Andrew J Preston; Craig M Keenan; Hazel Sutherland; Peter J Wilson; Brenda Wlodarski; Adam M Taylor; Dominic P Williams; Lakshminarayan R Ranganath; James A Gallagher; Jonathan C Jarvis
Journal:  Ann Rheum Dis       Date:  2013-03-19       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.